Nath Bio-Genes (India) Limited
NSE:NATHBIOGEN.NS
188.91 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 361.697 | 361.643 | -633.865 | 567.511 | 485.085 | 388.683 | 300.545 | 167.534 | 152.344 | 263.529 | 255.129 | 122.961 |
| Depreciation & Amortization
| 32.612 | 30.123 | 30.841 | 28.159 | 14.526 | 14.466 | 9.507 | 30.304 | 39.048 | 43.871 | 46.614 | 45.099 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 196.266 | -98.132 | -180.72 | -651.28 | -445.059 | -636.397 | -871.566 | -261.937 | -384.71 | -290.572 | -176.15 | -57.177 |
| Accounts Receivables
| 27.648 | -118.829 | 210.226 | -20.581 | 13.549 | -256.824 | -296.225 | -65.249 | -4.359 | -97.061 | -140.509 | -85.341 |
| Inventory
| -224.625 | 124.962 | 59.571 | -219.918 | -489.519 | -318.99 | 66.938 | 105.889 | -237.049 | -284.665 | -113.938 | -114.189 |
| Accounts Payables
| 155.606 | -150.461 | 199.922 | -229.73 | 180.044 | 136.02 | -77.535 | -35.986 | -36.072 | 0 | 0 | 0 |
| Other Working Capital
| 237.637 | 46.196 | -650.439 | -181.051 | -149.134 | -196.604 | -938.503 | -367.825 | -147.661 | -5.906 | -62.212 | 57.011 |
| Other Non Cash Items
| 130.822 | 90.034 | 954.207 | 66.739 | 40.192 | 13.363 | 91.679 | 97.533 | 51.639 | 50.727 | 24.688 | 31.225 |
| Operating Cash Flow
| 614.802 | 383.668 | 170.463 | 11.129 | 94.743 | -219.886 | -469.835 | 33.435 | -141.678 | 67.555 | 150.28 | 142.108 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -83.929 | -25.488 | -210.166 | -115.984 | -162.034 | -222.955 | -48.589 | -41.259 | -216.174 | -7.061 | -28.95 | -213.543 |
| Acquisitions Net
| 0.501 | 0.471 | 0.731 | 1.528 | 4.645 | 0.84 | 2.899 | 0.736 | 0.444 | 0 | 0 | 0 |
| Purchases Of Investments
| -9.98 | -0.002 | -0.155 | -0.502 | -0.002 | -0.002 | -0.002 | -0.002 | 0 | -0.002 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | -0.471 | -0.731 | -1.528 | -4.645 | -0.84 | 0 | 0 | 0 | 0 | 0 | 5.038 |
| Other Investing Activites
| -183.357 | -3.35 | 11.657 | 13.664 | 17.664 | 18.125 | 7.889 | 0.746 | 46.95 | -13.226 | -130.992 | 0.829 |
| Investing Cash Flow
| -277.265 | -28.84 | -198.664 | -102.822 | -144.372 | -204.832 | -40.702 | -40.516 | -169.224 | -20.29 | -159.942 | -207.676 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -7.667 | -122.537 | -78.202 | -252.201 | -121.094 | -253.446 | -363.254 | -149.877 | -371.138 | -6.712 | -2.816 | -4.504 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 1,365 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -38.008 | -38.008 | -38.008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.001 | 143.863 | -106.056 | 416.208 | 176.729 | 454.846 | -466.35 | 53.306 | 307.426 | -53.679 | 7.021 | 57.435 |
| Financing Cash Flow
| -45.674 | -16.682 | -222.266 | 164.007 | 55.635 | 201.4 | 898.65 | 53.306 | 307.426 | -53.679 | 7.021 | 57.435 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0.112 | -0 | 0.049 | -9.471 | 0 | 0 | 0 | 0 | 0 | -0 |
| Net Change In Cash
| 394.194 | 338.146 | -250.481 | 72.313 | 6.006 | -232.789 | 388.113 | 46.225 | -3.477 | -6.414 | -2.641 | -8.133 |
| Cash At End Of Period
| 774.096 | 379.952 | 41.68 | 292.161 | 219.799 | 213.793 | 446.583 | 58.47 | 12.245 | 15.721 | 22.135 | 24.776 |